Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 4 of the last 4 fiscal years.
-
Tight liquidity NBB
Cash and receivables cover 34 % of short-term debt in 2026; threshold 65 %.
Financials
Financial year 2026
REYNAERT RESEARCH from Gent, company number BE0466059759, closed financial year 2026 with a result of € 6,930 after tax. For that financial year REYNAERT RESEARCH recorded a gross margin of € 13,058 and equity of € -33,290. Compared with financial year 2025, the result moved from € 7,614 to € 6,930. The company is profitable. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on October 28, 2026.
€ -33,290
▲ € 6,930 vs 2025
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 6,930
▼ 9% vs 2025
Profit after tax over the fiscal year.
€ 24,664
▲ 32% vs 2025
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2026. Retained profit grew to € -51,882.
People and assets in 2026
≈ 1
No payroll staff. One director, so that person most likely runs the business.
Debts at end 2026
None
No bank loans on the last day of the fiscal year.
€ 2,739
▲ 229% vs 2025
Supplier invoices still open on the last day of the fiscal year.
€ 3,637
▲ 2% vs 2025
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2023 | 2024 | 2025 | 2026 | Change 2025 → 2026 | |
|---|---|---|---|---|---|
| Gross margin | € 2,367 | € 40,473 | € 13,822 | € 13,058 | ▼ 6% |
| Profit after taxes | € -10,715 | € 26,998 | € 7,614 | € 6,930 | ▼ 9% |
| Equity | € -74,833 | € -47,835 | € -40,220 | € -33,290 | ▲ € 6,930 |
| Total debts | € 109,343 | € 118,144 | € 96,916 | € 80,115 | ▼ 17% |
| Cash | € 15,135 | € 45,184 | € 18,666 | € 24,664 | ▲ 32% |
| Retained profit | € -93,425 | € -66,427 | € -58,812 | € -51,882 | ▲ € 6,930 |
| Balance sheet total | € 34,511 | € 70,309 | € 56,696 | € 46,825 | ▼ 17% |
Key figures of REYNAERT RESEARCH, fiscal years 2023 to 2026, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2027) expected before 31 October 2027.
What happened to REYNAERT RESEARCH?
What happened at REYNAERT RESEARCH in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2026: profit of € 6,930 (▼ 9% vs 2025). Source: NBB ↗
- New establishment in Gent. KBO
- Start of the company according to the CBE. KBO
- Herman Reynaert became a director. NBB
In short
From € 10,715 loss in 2023 to € 6,930 profit in 2026.
Paid € 19,473 in corporate taxes since 2023.
Best year ever: 2024, with € 26,998 profit.
Management
Behind REYNAERT RESEARCH is Herman Reynaert.
Directors
According to the 2026 annual accounts
Herman Reynaert
Director
since 1999
Establishments
Establishment units
Physical locations of this company
Nekkersvijverstraat 140
9040 Gent
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0466.059.759
- VAT number
- BE 0466.059.759
- Registered office
- Nekkersvijverstraat 140, 9040 Gent
- Names & denominations
- REYNAERT RESEARCH
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 12 May 1999
- Peppol
- Active · Active since 5 Dec 2025
- Activities · NACE
Groothandel in farmaceutische en medische artikelen
Groothandel in farmaceutische producten